Anti-infective Drugs Market - Size, Share, Outlook, and Analysis, 2018-2026

Page 1

Anti-infective Drugs Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2018-2026


REPORT DESCRIPTION Anti-infective Drugs Market – Overview Growth and multiplication of harmful pathogens such as bacteria, viruses, fungi, and parasites causes major infections in the host body. Infection can be transmitted through skin contact, bodily fluids, airborne particles, or touching an infected object. Anti-infective drugs are used for the treatment of infectious diseases or conditions. Anti-infective drugs act by inhibiting the growth or by eliminating the infectious agents. For instance, in September 2018, Xellia Pharmaceuticals, a specialty pharmaceutical company that offers anti-infective drugs against serious and often life-threatening infections, started its new office in Buffalo Grove, near Chicago, Illinois to expand its sales and manufacturing capabilities within the U.S. For instance, in September 2018, Astellas Pharma Inc. launched Dafclir Tablets 200 mg (fidaxomicin) for the treatment of infectious enteritis (including pseudomembranous colitis) in Japan. Astelles has also made an agreement with Merck in 2018 for development and marketing of Dafclir in Japan. Furthermore, increasing number of pipeline studies to develop anti-infective drugs for the treatment of rare infectious diseases is contributing to growth of the anti-infective drugs market.


REPORT DESCRIPTION Anti-infective Drugs Market Taxonomy: By Drug Class Type Anti-bacterial Drugs B – Lactams Quinolones Macrolides Tetracycline Aminoglycoside Others Anti-fungal Drugs Azoles Echinocandins Polyenes Get Request a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/2489


REPORT DESCRIPTION Anti-infective Drugs Market – Key Players Abbott Laboratories Alcon Pharmaceuticals Ltd  Astellas Pharma Inc  AstraZeneca Plc  Bayer HealthCare AG  Alkem Labs  Pacific India Pharma Limited  Pfizer For instance, in January 2018, Melinta Therapeutics, Inc. launched its intravenous and oral formulations of Baxdela (delafloxacin) in the U.S. Baxdela is intended for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by designated susceptible bacteria including gram positive bacteria and gram negative bacteria. Get More Inf @ https://www.coherentmarketinsights.com/ongoing-insight/anti-infective-drugs-market-2489  


ABOUT COHERENT MARKET INSIGHTS

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES INDUSTRY ANALYSIS MARKET INTELLIGENCE SERVICES

CUSTOMIZED RESEARCH CONSULT STUDIES

SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES


ABOUT CMI SECTOR COVERAGE

BIOTECHNOLOGY

CLINICAL DIAGNOSTIC

HEALTHCARE IT

MEDICAL DEVICES

MEDICAL IMAGING

PHARMACEUTICAL

OUR CLIENTS

      

Global Leading Equipment and System Manufacturers Component Providers and System Integrators Distributors, Retailors and Value Added Resellers Healthcare IT Solutions Developers Marketing Consultancies and the Advertising Industry Private and Government organization Outsourcing Companies


ABOUT US KEY STATS

RESEARCH SOLUTIONS

FEASIBILITY STUDIES

GLOBAL REPORTS

100+ Insights Published Per Year

150+

Consulting Projects Till Date

125+

Clients Worldwide Per Year

110+

COUNTRY ANALYSIS

CONSULT PROJECTS SURVEY RESEARCH

EXCEL FORECAST DATABASE

COMPETITIVE ASSESSMENT

TECHNOLOGY SNIPPETS

Analysts and Contract Consultants

Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique —we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.


THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.